These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 25351779)

  • 21. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A re-examination of the use of ethnicity in prenatal carrier testing.
    Ross LF
    Am J Med Genet A; 2012 Jan; 158A(1):19-23. PubMed ID: 22106058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.
    Su YN; Hung CC; Lin SY; Chen FY; Chern JP; Tsai C; Chang TS; Yang CC; Li H; Ho HN; Lee CN
    PLoS One; 2011 Feb; 6(2):e17067. PubMed ID: 21364876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-invasive prenatal testing for single gene disorders: exploring the ethics.
    Deans Z; Hill M; Chitty LS; Lewis C
    Eur J Hum Genet; 2013 Jul; 21(7):713-8. PubMed ID: 23188047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antenatal thalassaemia carrier testing: women's perceptions of "information" and "consent".
    Ahmed S; Green J; Hewison J
    J Med Screen; 2005; 12(2):69-77. PubMed ID: 15949117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal diagnosis of hemoglobinopathies.
    Fischel-Ghodsian N
    Clin Perinatol; 1990 Dec; 17(4):811-28. PubMed ID: 2286030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal genetic testing for cystic fibrosis: a systematic review of clinical effectiveness and an ethics review.
    Kessels SJM; Carter D; Ellery B; Newton S; Merlin TL
    Genet Med; 2020 Feb; 22(2):258-267. PubMed ID: 31467445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal diagnosis of spinal muscular atrophy by genetic analysis of circulating fetal cells.
    Béroud C; Karliova M; Bonnefont JP; Benachi A; Munnich A; Dumez Y; Lacour B; Paterlini-Bréchot P
    Lancet; 2003 Mar; 361(9362):1013-4. PubMed ID: 12660061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive prenatal diagnosis of spinal muscular atrophy by relative haplotype dosage.
    Parks M; Court S; Bowns B; Cleary S; Clokie S; Hewitt J; Williams D; Cole T; MacDonald F; Griffiths M; Allen S
    Eur J Hum Genet; 2017 Apr; 25(4):416-422. PubMed ID: 28120840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation challenges for an ethical introduction of noninvasive prenatal testing: a qualitative study of healthcare professionals' views from Lebanon and Quebec.
    Haidar H; Vanstone M; Laberge AM; Bibeau G; Ghulmiyyah L; Ravitsky V
    BMC Med Ethics; 2020 Feb; 21(1):15. PubMed ID: 32041603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. For your interest? The ethical acceptability of using non-invasive prenatal testing to test 'purely for information'.
    Deans Z; Clarke AJ; Newson AJ
    Bioethics; 2015 Jan; 29(1):19-25. PubMed ID: 25521970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-cultural perspectives on decision making regarding noninvasive prenatal testing: A comparative study of Lebanon and Quebec.
    Haidar H; Vanstone M; Laberge AM; Bibeau G; Ghulmiyyah L; Ravitsky V
    AJOB Empir Bioeth; 2018; 9(2):99-111. PubMed ID: 29847254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GPs' opinions of their role in prenatal genetic services: a cross-sectional survey.
    Qureshi N; Armstrong S; Modell B
    Fam Pract; 2006 Feb; 23(1):106-10. PubMed ID: 16115832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.
    Ngan OMY; Yi H; Wong SYS; Sahota D; Ahmed S
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):285. PubMed ID: 28870159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal screening: an ethical agenda for the near future.
    de Jong A; de Wert GM
    Bioethics; 2015 Jan; 29(1):46-55. PubMed ID: 25521973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population screening for reproductive risk for single gene disorders in Australia: now and the future.
    Delatycki MB
    Twin Res Hum Genet; 2008 Aug; 11(4):422-30. PubMed ID: 18637742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delay between pregnancy confirmation and sickle cell and [corrected] thalassaemia screening: a population-based cohort study.
    Dormandy E; Gulliford MC; Reid EP; Brown K; Marteau TM;
    Br J Gen Pract; 2008 Mar; 58(548):154-9. PubMed ID: 18318968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Innovative Prenatal Testing: Clinical Applications and Ethical Considerations].
    Huang MC; Lin SJ; Chen CL; Huang TJ
    Hu Li Za Zhi; 2017 Oct; 64(5):5-10. PubMed ID: 28948585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disclosing to parents newborn carrier status identified by routine blood spot screening.
    Oliver S; Dezateux C; Kavanagh J; Lempert T; Stewart R
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003859. PubMed ID: 15495068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues.
    Minear MA; Alessi S; Allyse M; Michie M; Chandrasekharan S
    Annu Rev Genomics Hum Genet; 2015; 16():369-98. PubMed ID: 26322648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.